Cytokinetics, Incorporated (CYTK)

NASDAQ: CYTK · IEX Real-Time Price · USD

56.41

+0.50 (0.89%)

At close: Jul 19, 2024, 4:00 PM

56.42

+0.01 (0.02%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Cytokinetics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2001
Revenue	3.75	7.53	94.59	70.43	55.83	26.87	Upgrade
Revenue Growth (YoY)	-96.17%	-92.04%	34.30%	26.15%	107.79%	-14.71%	Upgrade
Gross Profit	3.75	7.53	94.59	70.43	55.83	26.87	Upgrade
Selling, General & Admin	169.45	173.61	177.98	96.8	52.82	39.61	Upgrade
Research & Development	332.27	330.12	240.81	159.94	96.95	86.13	Upgrade
Operating Expenses	501.72	503.74	418.79	256.74	149.77	125.74	Upgrade
Operating Income	-497.97	-496.21	-324.2	-186.31	-93.94	-98.87	Upgrade
Interest Expense / Income	28.45	28.31	19.41	16.44	15.96	6.62	Upgrade
Other Expense / Income	4.18	1.73	45.34	12.56	17.38	16.2	Upgrade
Pretax Income	-530.6	-526.24	-388.96	-215.31	-127.29	-121.69	Upgrade
Net Income	-530.6	-526.24	-388.96	-215.31	-127.29	-121.69	Upgrade
Shares Outstanding (Basic)	102	97	90	77	65	58	Upgrade
Shares Outstanding (Diluted)	102	97	90	77	65	58	Upgrade
Shares Change	7.10%	7.46%	16.83%	19.16%	12.07%	5.80%	Upgrade
EPS (Basic)	-5.40	-5.45	-4.33	-2.80	-1.97	-2.11	Upgrade
EPS (Diluted)	-5.40	-5.45	-4.33	-2.80	-1.97	-2.11	Upgrade
Free Cash Flow	-422.57	-415.75	-310.85	-191.39	-2.11	-93.53	Upgrade
Free Cash Flow Per Share	-4.15	-4.31	-3.46	-2.49	-0.03	-1.62	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-13272.04%	-6589.71%	-342.75%	-264.54%	-168.27%	-367.97%	Upgrade
Profit Margin	-14141.74%	-6988.63%	-411.21%	-305.72%	-228.00%	-452.93%	Upgrade
Free Cash Flow Margin	-11262.47%	-5521.24%	-328.64%	-271.76%	-3.78%	-348.09%	Upgrade
EBITDA	-489.78	-486.05	-363.73	-196.6	-109.5	-113.78	Upgrade
EBITDA Margin	-13053.70%	-6454.79%	-384.54%	-279.15%	-196.13%	-423.46%	Upgrade
Depreciation & Amortization	12.38	11.89	5.81	2.28	1.83	1.29	Upgrade
EBIT	-502.15	-497.94	-369.54	-198.87	-111.33	-115.07	Upgrade
EBIT Margin	-13383.53%	-6612.72%	-390.68%	-282.38%	-199.41%	-428.28%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).